Literature DB >> 10556682

Cardiovascular responses to cocaine self-administration: acute and chronic tolerance.

S R Tella1, C W Schindler, S R Goldberg.   

Abstract

The nature and the mechanism of tolerance to the cardiovascular responses to cocaine self-administration were studied in rats implanted with telemetric devices. The first infusion of cocaine (1 mg/kg/infusion) on day 1 of testing produced rapid and brief increases in mean arterial blood pressure and in heart rate. Subsequent infusions in the same session produced minimal effects. With chronic testing, there were gradual reductions in cardiovascular responses to the first infusion in the daily session and enhancements in the daily cocaine intake, with significant changes occurring by the fourth week of the testing. Following saline extinction testing (for 5 days), reinstatement of cocaine during week 6 led to a partial and short lasting (</=3 sessions) recovery from the chronic tolerance to the rapid cardiovascular responses to cocaine. There were significant enhancements in cardiovascular responses to post-session norepinephrine during week 2 and marked reductions during week 6 as compared to corresponding control responses. There were marked reductions in the cardiovascular responses to post-session tyramine tested during week 3. These data indicate that self-administered cocaine produces rapid and brief cardiovascular responses which undergo both within-session acute tolerance and a between-session, reversible chronic tolerance. Adrenergic adaptive mechanisms mediate the chronic tolerance. The development of chronic cardiovascular tolerance to cocaine temporally parallels that of the apparent tolerance to its reinforcing effects. Doses of cocaine that maintain self-administration behavior inhibit the norepinephrine transporter at peripheral sympathetic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556682     DOI: 10.1016/s0014-2999(99)00582-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

1.  Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice.

Authors:  Jonathan A Zombeck; Tripta Gupta; Justin S Rhodes
Journal:  Psychopharmacology (Berl)       Date:  2008-09-17       Impact factor: 4.530

2.  Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats.

Authors:  Chloe J Jordan; Bree A Humburg; Eric B Thorndike; Anver Basha Shaik; Zheng-Xiong Xi; Michael H Baumann; Amy Hauck Newman; Charles W Schindler
Journal:  J Pharmacol Exp Ther       Date:  2019-09-27       Impact factor: 4.030

3.  Enhanced neuronal and blunted hemodynamic reactivity to cocaine in the prefrontal cortex following extended cocaine access: optical imaging study in anesthetized rats.

Authors:  Craig P Allen; Kicheon Park; Ang Li; Nora D Volkow; George F Koob; Yingtian Pan; Xiu-Ti Hu; Congwu Du
Journal:  Addict Biol       Date:  2018-03-05       Impact factor: 4.280

4.  Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

Authors:  Charles W Schindler; Marzena Karcz-Kubicha; Eric B Thorndike; Christa E Müller; Srihari R Tella; Sergi Ferré; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

5.  Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.

Authors:  Charles W Schindler; Eric B Thorndike; Bruce E Blough; Srihari R Tella; Steven R Goldberg; Michael H Baumann
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

6.  Patterns of functional activity associated with cocaine self-administration in the rat change over time.

Authors:  Darrel J Macey; Wendy N Rice; Cory S Freedland; Christopher T Whitlow; Linda J Porrino
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

7.  Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

Authors:  Michael H Baumann; John S Partilla; Kurt R Lehner; Eric B Thorndike; Alexander F Hoffman; Marion Holy; Richard B Rothman; Steven R Goldberg; Carl R Lupica; Harald H Sitte; Simon D Brandt; Srihari R Tella; Nicholas V Cozzi; Charles W Schindler
Journal:  Neuropsychopharmacology       Date:  2012-10-17       Impact factor: 7.853

8.  Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence.

Authors:  D B Vaupel; C W Schindler; S Chefer; A M Belcher; I Ahmet; K B Scheidweiler; M A Huestis; E A Stein
Journal:  Drug Alcohol Depend       Date:  2015-12-24       Impact factor: 4.492

9.  Comparing the physiological and subjective effects of self-administered vs yoked cocaine in humans.

Authors:  Eric C Donny; George E Bigelow; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2006-03-21       Impact factor: 4.530

10.  Methylenedioxypyrovalerone (MDPV) mimics cocaine in its physiological and behavioral effects but induces distinct changes in NAc glucose.

Authors:  Ken T Wakabayashi; Suelynn E Ren; Eugene A Kiyatkin
Journal:  Front Neurosci       Date:  2015-09-17       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.